Page 134 - Demo
P. 134


                                    PCR Partners (\rivate equity sponsors, family offices and corporate clients who need to see additional high-quality deal flow. PCR works in partnership with clients as an outsourced business development group, and PCR has co-invested in most deals closed with its clients. PCR sources and originates acquisition opportunities that fit client criteria profiles on both a generalist, opportunistic basis, and a specific search basis. PCR sources opportunities primarily from a network of boutique investment bankers, advisors and key professionals who may be retained on the sell side to create liquidity for owners of companies at a crossroads in their overall development. Targets typically have $15mm to $350mm in Revenues and $3mm to $40mm in historical EBITDA, and are usually family or entrepreneur owned, in change of control transactions. You can learn more about how we work with our clients to develop acquisition strategies and how we implement and execute these strategies at www.pcrllc.com. You will also find detailed information on our current acquisition criteria and parameters as well as background information on the firm%u2019s principals. Investment criteria for our currently retained private equity and family office clients include the following: Size Parameter and Financial Metrics:%u2022 $3-$40mm in historical EBITDA%u2022 Management that is willing to stay/recapitalize with new owner, or 100% buyout transactions%u2022 10% or better EBITDA margins%u2022 Control position or a minority equity/sub-debt position in certain casesIndustry Categories:%u2022 Industrial Manufacturing%u2022 Business Services%u2022 High Tolerance, Precision Manufacturing %u2022 Engineered Products%u2022 Building Products%u2022 Distribution/Supply Chain Logistics%u2022 Food Ingredients (Human and Pet)%u2022 Healthcare Services%u2022 Education and Training Services%u2022 Niche Financial Services%u2022 Positive Social Impact%u2022 Consumer Products and ServicesSpecial Areas of Past Success:%u2022 Specialty Logistics and Air Cargo Handling%u2022 Building Products (Distribution and Manufacturing)%u2022 Retina Surgery Practices (Ophthalmology)%u2022 General Aviation Product Manufacturing%u2022 Consumer Products and Services%u2022 Industrial Products Manufacturing%u2022 Food Industry Safety and Logistics%u2022 Outsourced Program Administration/Consulting%u2022 Gears and Power Generation Product Manufacturing%u2022 Impact Investing in Education and Healthcare%u2022 Supply Chain Logistics, Virtual Manufacturing%u2022 B2B Product Manufacturing%u2022 Testing and Monitoring Equipment and Services%u2022 SAAS Software Solutions%u2022 Governmental Financial Advisor/Asset Manager%u2022 Assembly Tooling Systems Manufacturing for Aerospace/Defense%u2022 Corporate Executive Relocation LogisticsGraeme FrazierPresident610-825-1153bgfrazier@pcrllc.comJoseph MorrisManaging Director610-825-1193jmorris@pcrllc.comQuint FrazierVice President610-247-4848qfrazier@pcrllc.comKen WalserSenior Associate610-825-3995kwalser@pcrllc.comPCR Partners2176 Harts Lane %u2022 Conshohocken, PA 19428 %u2022 www.pcrllc.com Buy-Side M&A
                                
   128   129   130   131   132   133   134   135   136   137   138